New Skin Patch Shows Promise Against Alzheimer's

A new skin patch that aids in improving the memory in those with Alzheimer's.

The National Institute for Health and Clinical Excellence had banned Aricept (donepezil), Reminyl (galantamine) and Exelon (rivastigmine).

Alzheimer’s disease - Causes, Symptoms, Diagnosis, Stages, Types, Prevention, Prognosis & Treatment
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.

But in a major U-turn, the UK's drug rationing body has agreed to let those in the early stages of the devastating disease have access to three life-boosting drugs.

Although the drugs cannot cure Alzheimer's, they improve functioning, such as the ability to pay attention and plan.

They have also been shown to increase alertness, improve mood and restore confidence, and there is evidence they can alleviate anxiety, depression and apathy.

Caring for Alzheimers disease patients
Alzheimer's disease is a complex brain disorder that triggers the most common form of dementia. The slide show will show how patients need support and care as dementia progresses.

Exelon can be taken as a pill, an oral solution or a skin patch. The patch has been shown to reduce side effects such as nausea and vomiting, which often occur when taking the medicine orally.

"These drugs hold the promise of relief from the symptoms of Alzheimer's for thousands of people and, while not the cure we desperately need, they can still help," the Daily Express quoted Rebecca Wood, chief executive of the Alzheimer's Research Trust, as saying.

Cleansing Alzheimer's Plaques With New Method
New molecular tools that 'cleanse' the brain of amyloid plaques, thought to be one of the factors in Alzheimer's disease, have been developed by scientists at the University of Michigan.

Source-ANI

Structural Brain Changes in People with Alzheimer's Risk Revealed in MRI Scans
A new study by neuroscientists at Rush University Medical Center has pointed out that, MRI scans of those at risk of developing Alzheimer's disease portray structural changes in the brain.